Off-Label Use Of Stryker Wingspan Stent Could Pose Serious Risks: US FDA
Executive Summary
The agency issued a recent safety alert against off-label use of Stryker’s Wingspan Stent. Based on a postmarket study, regulators found higher rates of stroke and death in patients who were treated with the stent for other than its approved indication.